www.fdanews.com/articles/132479-seattle-genetics-to-submit-lymphoma-drug-to-fda

Seattle Genetics to Submit Lymphoma Drug to FDA

December 6, 2010

A pivotal trial of Seattle Genetics’ experimental cancer-targeting antibody for patients with Hodgkin’s lymphoma found that more than a third of them achieved complete remission of their cancer.
Fox News